Five Prime Therapeutics downgraded by Jefferies with a new price target
$FPRX
Major Pharmaceuticals
Health Care
Jefferies downgraded Five Prime Therapeutics from Buy to Hold and set a new price target of $38.00
Save time and jump to the most important pieces.